• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EXACTECH, INC. NV GXL LNR, +5LAT, 32MM G2-52/54MM CUPS; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, CEMENTED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EXACTECH, INC. NV GXL LNR, +5LAT, 32MM G2-52/54MM CUPS; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, CEMENTED Back to Search Results
Model Number NV GXL LNR, +5LAT, 32MM G2-52/54MM CUPS
Medical Device Problem Code Naturally Worn (2988)
Health Effect - Clinical Code Failure of Implant (1924)
Date of Event 08/30/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Additional information, including the product investigation, will be submitted within 30 days of receipt.
 
Event or Problem Description
As reported by the german competent authorities indicates that as part of the manufacturer's recall campaign, the patient presented for a check on the hip prosthesis implanted in 2015.The x-ray control showed a clear decentering of the prosthesis head and unusually coarse osteolysis in the acetabulum as a sign of inlay wear.This could be verified when the inlay was changed on (b)(6), 2023 to a vitd-hardened, specially approved inlay.As part of the replacement operation, in addition to replacing the inlay, the firm acetabular integrity was determined, the cysts in the acetabulum were treated and sealed using allogeneic spongiosa, and the prosthesis head was replaced.The explants are currently in the hospital's laboratory for microbiological examination using sonication.After completion of the examination (14 days long-term incubation), these are made available to the manufacturer on request for further material-technical examination.Surgical reports/x-rays are also made available on request; however, pending patient's consent.
 
Additional Manufacturer Narrative
These devices are used for treatment, not diagnosis.H6.Investigation results - based on the available information, the patient involved risk criteria for early prosthesis wear/osteolysis -implanted with a lateralized liner.The most likely cause for the revision reported due to prosthesis wear is a combination of risk factors including, use error, implant positioning, implant size selection, and patient factors may have also been a contributing factor to the early prosthesis wear.However, this cannot be confirmed since the device was not available for evaluation and images or radiographs were not provided.There is no other information provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NV GXL LNR, +5LAT, 32MM G2-52/54MM CUPS
Common Device Name
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, CEMENTED
Manufacturer (Section D)
EXACTECH, INC.
2320 nw 66 court
gainesville FL 32653
Manufacturer (Section G)
EXACTECH, INC.
2320 nw 66 court
gainesville FL 32653
Manufacturer Contact
michael crader
3523771140
MDR Report Key17786263
Report Number1038671-2023-02333
Device Sequence Number17670776
Product Code JDI
UDI-Device Identifier10885862024282
UDI-Public10885862024282
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
K070479
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2015
Device Explanted Year2023
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional
Initial Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup
Report Date (Section B) 02/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/17/2019
Device Model NumberNV GXL LNR, +5LAT, 32MM G2-52/54MM CUPS
Device Catalogue Number136-32-52
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Supplement Date Received by Manufacturer12/20/2023
Initial Report FDA Received Date09/20/2023
Supplement Report FDA Received Date02/20/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured06/18/2014
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
Z-1729-2022
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexFemale
-
-